One-Pot Regioselective Synthesis of 2,6,9-Trisubstituted Adenines

Abstract

A series of 2,6,9-substituted adenines were obtained from the easily accessible 5-amino-4-cyanoformimidoyl imidazoles, acetic and benzoic anhydrides, and primary alkyl amines in a three-step sequence. Acylation of 5-amino-4-cyanoformimidoyl imidazoles followed by addition of the amine led to the intermediates 5-amino-4-(N-acyl)formamidino imidazoles under mild conditions. Cyclization of 5-amino-4-(N-acyl)formamidino imidazoles under reflux in ethanol led to the desired substituted adenine. A preliminary stepwise study led to the development of three general and efficient one-pot methods for the synthesis of adenine derivatives. The one-pot, three-step reaction in the presence of DMAP was the most convenient synthetic approach.

heterocycles - cyclization - ring closure - ring opening - imidazole - purine

References and Notes

1 Verma S. Mishra AK. Kumar J. Acc. Chem. Res.  2010,  43:  79 

2a Legraverend M. Grierson DS. Bioorg. Med. Chem.  2006,  14:  3987 ; and references therein

2b Legraverend M. Tetrahedron  2008,  64:  8585 ; and references therein

3 Baraldi PG. Tabrizi MA. Gessi S. Borea PA. Chem. Rev.  2008,  108:  238 

4a Zhang C. Shokat KM. Tetrahedron  2007,  63:  5832 

4b Huang H. Mab J. Shi J. Meng L. Jiang H. Ding J. Liu H. Bioorg. Med. Chem.  2010,  18:  4615 

5 Zacharie B. Fortin D. Wilb N. Bienvenu J.-F. Asselin M. Grouix B. Penney C. Bioorg. Med. Chem. Lett.  2009,  19:  242 

6 Tang Y.-b. Peng Z.-g. Liu Z.-y. Li Y.-p. Jiang J.-d. Li Z.-r. Bioorg. Med. Chem. Lett.  2007,  17:  6350 

7a Tunçbilek M. Ates-Alagöz Z. Altanlar N. Karayel A. Özbey S. Bioorg. Med. Chem.  2009,  17:  1693 

7b Geng B. Breault G. Comita-Prevoir J. Petrichko R. Eyermann C. Lundqvist T. Doig P. Gorseth E. Noonan B. Bioorg. Med. Chem. Lett.  2008,  18:  4368 

8 Goswami P. Das B. Tetrahedron Lett.  2009,  50:  2384 

9a Mitsunobu O. Synthesis  1981,  1 

9b Rad M. Khalafi-Nezhad A. Behrouz S. Faghihi M. Zare Parhami A. Tetrahedron  2008,  64:  1778 

9c Aguado L. Thibaut HJ. Priego E.-M. Jimeno M.-L. Camarasa M.-J. Neyts J. Perez-Perez M.-J. J. Med. Chem.  2010,  53:  316 

9d Giorgi I. Biagi G. Livi O. Leonardi M. Scartoni V. Pietra D. Arch. Pharm. Chem. Life Sci.  2007,  340:  81 

10a Montgomery JA. Thomas HJ. J. Med. Chem.  1972,  15:  182 

10b Kadir K. Shaw G. Wright D. J. Chem. Soc. Perkin Trans. 1  1980,  2728 

11a Alves MJ. Booth BL. Freitas AP. Proença MF. J. Chem. Soc., Perkin Trans. 1  1992,  913 

11b Booth BL. Dias AM. Proença MF. J. Chem. Soc., Perkin Trans. 1  1992,  2119 

11c Alves MJ. Booth BL. Proença MF.
J. Heterocycl. Chem.  1994,  31:  345 

11d Booth BL. Coster RD. Proença MF. Synthesis  1988,  389 

11e Alves MJ. Booth BL. Carvalho MA. Pritchard RG. Proença MF. J. Heterocycl. Chem.  1997,  739 

11f Al-Azmi A. Booth BL. Carpenter RA. Carvalho MA. Marrelec E. Pritchard RG. Proença MF. J. Chem. Soc., Perkin Trans. 1  2001,  2532 

11g Booth BL. Cabral IM. Dias AM. Freitas AP. Matos-Beja AM. Proença MF. Ramos-Silva M. J. Chem Soc., Perkin Trans. 1  2001,  1241 

11h Carvalho MA. Esteves TM. Proença MF. Booth BL. Org. Biomol. Chem.  2004,  2:  1019 

11i Carvalho MA. Álvares Y. Zaki ME. Proença MF. Booth BL. Org. Biomol. Chem.  2004,  2:  2340 

11j Carvalho MA. Esperança S. Esteves T. Proença MF. Eur. J. Org. Chem.  2007,  1324 

11k Dias AM. Cabral I. Vila-Chã AS. Costa DS. Proença MF. Eur. J. Org. Chem.  2007,  1925 

11l Alves MJ. Carvalho MA. Carvalho S. Dias AM. Fernandes FH. Proença MF. Eur. J. Org. Chem.  2007,  4881 

11m Correia C. Carvalho MA. Proença MF. Tetrahedron  2009,  65:  6903 

11n Ribeiro A. Carvalho MA. Proença MF. Eur. J. Org. Chem.  2009,  4867 

11o Bacelar AH. Carvalho MA. Proença MF. Eur. J. Org. Chem.  2010,  3234 

12a Dias AM. Cabral IM. Vila-Chã AS. Proença MF. Synlett  2007,  1231 

12b Dias AM. Cabral IM. Vila-Chã AS. Cunha D. Senhorães N. Nobre S. Sousa C. Proença MF. Synlett  2010,  2792 

13

General Procedure for the Synthesis of 4a-d Benzylamine (1.1 equiv for 4a,b), methylamine (for 4c), or isopropylamine (for 4d) was added to a suspension of the acylated imidazole 2 (0.59-2.82 mmol) in MeCN (0.5 mL), and the mixture turned immediately into a beige solution. The mixture was stirred at 0 ˚C (20 min for 4a, 10 min for 4b, and 5 min for 4c) or at r.t. (10 min for 4d). Bright white solids precipitated and were filtered and washed with MeCN and Et₂O to give compounds 4a-d (44-63%). The structure of the products was confirmed by elemental analysis, ^¹H NMR, and ^¹³C NMR spectroscopy.
Characterization of N -[(5-Amino-1-phenyl-1 H -imidazol-4-yl)benzylaminomethylene]acetamide (4a)
Mp 159.1-160.2 ˚C. ^¹H NMR (300 MHz, DMSO-d ₆): δ = 11.69 (br s, 1 H), 7.58 (m, 2 H), 7.52-7.47 (m, 3 H), 7.49 (s, 1 H), 7.40-7.30 (m, 5 H), 7.30 (br s, 2 H), 5.32 (br s, 2 H), 1.98 (s, 3 H). ^¹³C NMR (75 MHz, DMSO-d ₆): δ = 182.93, 161.94, 147.19, 139.09, 131.30, 129.91, 129.05, 128.51, 128.28, 127.23, 126.19, 124.97, 111.32, 47.41, 28.19. Anal. Calcd for C₁₉H₁₉N₅O: C, 68.45; H, 5.74; N, 21.01. Found: C, 68.51; H, 5.61; N, 21.41. IR (mull): 3374, 3256, 1620, 1549, 1455 cm^-¹.

14

General Procedure for the Synthesis of 7c
Method B
A beige suspension of the imidazole 3 (0.82 mmol) in MeCN (2 mL) stirred at r.t. was combined with benzylamine (1.2 equiv). After 2 h, the mixture turned to an orange solution and was heated under reflux for 7 h. After cooling, the product precipitated out of solution, and the solid was filtered and washed with MeCN and Et₂O to give compound 7c (50% yield).
Method C
Benzoic anhydride (2 equiv) was added to a beige suspension of imidazole 1 in MeCN (4 mL), and the mixture was stirred at r.t. for 5 h, when the mixture turned into an orange suspension. Benzylamine (1.2 equiv) and EtOH (4 mL) were added, and the mixture was heated under reflux for 5 h. After cooling, a solid precipitated out of solution and was filtered and washed with MeCN, EtOH, and Et₂O to give compound 7c (63%).
Characterization of N -Benzyl-2-phenyl-9-( p -tolyl)-9 H -purin-6-amine (7c)
Mp 199.8-200.7 ˚C. ^¹H NMR (300 MHz, DMSO-d ₆): δ = 8.57 (s, 1 H), 8.56 (br s, 1 H), 8.34 (d, J = 7.2 Hz, 2 H), 7.93 (d, J = 8.4 Hz, 2 H), 7.83 (d, J = 8.4 Hz, 2 H), 7.47-7.41 (m, 3 H), 7.38 (d, J = 7.6 Hz, 2 H), 7.30 (t, J = 7.6 Hz, 2 H), 7.20 (t, J = 7.6 Hz, 1 H), 4.85 (br s, 2 H), 2.39 (s, 3 H). ^¹³C NMR (75 MHz, DMSO-d ₆): δ = 158.00, 154.29, 149.49, 140.35, 139.96, 138.38, 136.85, 132.73, 129.66, 129.14, 128.19, 128.12, 127.64, 127.39, 126.62, 122.84, 118.73, 43.17, 20.57. Anal. Calcd for C₂₅H₂₁N₅: C, 76.70; H, 5.41; N, 17.89. Found: C, 76.70; H, 5.24; N, 17.64. IR (mull): 3270, 3084, 1623, 1571, 1529, 1519, 1496 cm^-¹.

15

General Procedure for the Synthesis of 8a
A yellow suspension of imidazole 2 (1.82 mmol) in EtOH (50 mL) was stirred at r.t. for 50 min. Benzylamine (1.1 equiv) was added to this solution and 10 min later, the mixture was evaporated in vacuum (30 ˚C). The residual oil was cooled and a solid precipitated by addition of acetone. The solid was filtered and washed with EtOH and Et₂O to give compound 8a (91%).
Characterization of N -{4-[(benzylamino)(imino)methyl]-1-phenyl-1 H -imidazol-5-yl}acetamide (8a)
Mp 160.6-161.5 ˚C. ^¹H NMR (300 MHz, DMSO-d ₆): δ = 7.81 (s, 1 H), 7.46-7.43 (m, 5 H), 7.43-7.34 (m, 5 H), 4.50 (s, 2 H), 1.72 (s, 3 H). ^¹³C NMR (75 MHz, DMSO-d ₆): δ = 171.83, 155.80, 148.66, 138.73, 136.01, 134.17, 129.08, 128.32, 127.44, 126.92, 124.09, 115.21, 45.52, 24.78. Anal. Calcd for C₁₉H₁₉N₅O: C, 68.45; H, 5.74; N, 21.01. Found: C, 68.41; H, 5.75; N, 20.86. IR (mull) 3370, 3251, 1631, 1551 cm^-¹.

General Procedure for the Synthesis of 6a

16a

Method A
A white suspension of 4a (1.75 mmol) in EtOH (2 mL) was heated at reflux for 5 min. The solution was evaporated in vacuum and after cooling, a white solid precipitated out of solution. The bright white solid was filtered and washed with EtOH and Et₂O to give compound 6a (92%).

16b

A suspension of imidazole 8a in EtOH (2 mL) was heated under reflux for 5 min. After that, the solution was evaporated in vacuum and, after cooling, a solid precipitated out of solution. The bright white solid was filtered and washed with EtOH and Et₂O to give compound 6a (87% yield). The structure of the product obtained was confirmed by elemental analysis, ^¹H NMR and ^¹³C NMR spectroscopy.
Method D
Acetic anhydride (1.2 equiv) and DMAP (1.5 equiv) were added to a beige suspension of 1 (1.80 mmol) in MeCN (1 mL) at 0 ˚C. The mixture immediately turned in an orange solution and 3 min later, a white solid precipitated out of solution. The solid was filtered and benzylamine (1.2 equiv) and EtOH (2 mL) were added, and the mixture was heated under reflux for 1 h. After cooling, a white solid precipitated out of solution and it was filtered and washed with EtOH and Et₂O to give compound 6a (76% yield).


Characterization of N -Benzyl-2-methyl-9-phenyl-9 H -purin-6-amine (6a)
Mp 175.6-176.7 ˚C. ^¹H NMR (300 MHz, DMSO-d ₆):
δ = 8.48 (s, 1 H), 8.30 (br s, 1 H), 7.85 (d, J = 7.8 Hz, 2 H), 7.57 (t, J = 7.8 Hz, 2 H), 7.43 (t, J = 7.8 Hz, 1 H), 7.38 (d, J = 6.9 Hz, 2 H), 7.30 (t, J = 6.9 Hz, 2 H), 7.20 (t, J = 6.9 Hz, 1 H), 4.80 (br s, 2 H)), 2.42 (s, 3 H). ^¹³C NMR (75 MHz, DMSO-d ₆): δ = 161.84, 154.32, 149.39, 140.21, 139.11, 135.15, 129.46, 128.19, 127.61, 127.60, 126.19, 123.15, 117.95, 42.60, 26.11. Anal. Calcd for C₁₉H₁₇N₅: C, 72.36; H, 5.43; N, 22.21. Found: C, 72.21; H, 5.28; N, 22.06. IR (mull): 3270, 3223, 3063, 1617, 1598, 1581, 1530 cm^-¹.